TU 025 Keishi Bukuryo Gan for Post-menopausal Hot Flash Management
Completed · Phase 2
Conditions studied: Hot Flashes, Menopause
In brief
This study tests to see if TU 025 Keishi Bukuryo Gan reduces the frequency and severity of hot flashes in post-menopausal American women. This study will also estimate the best dose amount and determine the common short-term side effects and risks.
Key facts
- Study ID
- NCT00119418
- Run by
- Plotnikoff, Gregory A., M.D.
- People needed
- 180
- Starts
- 2004-11-01
- Expected to finish
- 2006-02-01
- Last updated by the study team
- 2010-10-26
Who can join
Age: 45 and older, up to 58. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Post-menopausal women aged 45-58 with an adequate hot flash frequency severity score. Post-menopause is defined as amenorrhea for at least 12 months, or post-hysterectomy for more than one year with follicle-stimulating hormone levels greater than or equal to 40 mIU/mL and estradiol (E2) levels of less than or equal to 20 pg/mL, or greater than two months post oophorectomy.
- All subjects must be up to date with both pap and mammogram screening by the US Preventative Services Taskforce Guidelines for the length of the trial.
- All subjects on any prescription medication need the approval of their prescribing physician for participation in the trial.
You may not qualify if…
- Concurrent hot flash therapies (prescription medications including hormones, antidepressants, SERMs, gabapentin or over the counter supplements)
- Moderately severe disease state(s) or diseases that affect absorption/metabolism, or diseases that mimic menopausal hot flashes.
- Inability to swallow vitamin size pills
- Beck depression inventory score greater than 11
- Greater than 10 cigarettes per day
- Abnormal liver function
- Treated or untreated hypertension greater than 160/90.
- BMI greater than 36
- Inability to give consent or commit to the length of the trial
- Known hypersensitivity to ingredients
- Physician judgment
Where it is running
- University of Minnesota General Clinical Research Center — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.